Advertisement

Advertisement

Most Viewed Videos
Frederick L. Locke, MD, on Innovative CAR-T Cell Therapies: The Patient Experience
Eric Jonasch, MD, on Kidney Cancer: A Year in Review
Heather A. Wakelee, MD, on Advanced Non–Small Cell Lung Cancer: State-of-the-Art Treatment for EGFR-Positive and ALK-Positive Diseases
Susan Y. Wu, MD, on Non–Small Cell Lung Cancer: Using an Online Tool in Treatment
Gary H. Lyman, MD, MPH, on Myeloid Growth Factors: New Biosimilar Approvals
Kyle F. Concannon, MD, on Lung Cancer in Homeless Patients: Outcomes and Quality Measures
Neil P. Shah, MD, PhD, on CML: NCCN Guidelines Updates on Discontinuing Tyrosine Kinase Inhibitor Therapy
Margaret A. Tempero, MD, on Pancreatic Cancer: NCCN Guidelines Updates
William J. Gradishar, MD, on HR-Positive, HER2-Negative Advanced Breast Cancer: NCCN Guidelines Updates
Stage III Non–Small Cell Lung Cancer: A Look at New Systemic Treatments
Leora Horn, MD, on Small Cell Lung Cancer and Immuno-oncology: Have We Finally Solved the Small Cell Paradox?
Shraddha M. Dalwadi, MD, MBA, on Non–Small Cell Lung Cancer: What Contributes to Disparities in Treating Stage I Disease
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Ruqin Chen, MB, on Lung Cancer Treated With Immune Checkpoint Inhibitors: Survival Outcomes and Clinical and Molecular Features
Karim Fizazi, MD, PhD: We Need to Find a Way to Make Cancer Drugs Affordable
Martin Edelman, MD, on Immunotherapy: How Safe Is It for Patients With Autoimmune Disease?
Matthew A. Gubens, MD, on Non–Small Cell Lung Cancer: New Immunotherapy Strategies in the NCCN Guidelines
J. Fletcher Drogos, MD, on Multiple Courses of Stereotactic Body Radiation Therapy: Outcomes in Patients With Lung Cancer
Aaron S. Mansfield, MD, on Treating Rare Thoracic Cancers: Status Update
Mark K. Ferguson, MD, on Mitigating Frailty and Sarcopenia to Improve Treatment Outcomes

Advertisement

Advertisement



;
Advertisement